Alpha Mark Advisors, LLC Amgen Inc Call Options Transaction History
Alpha Mark Advisors, LLC
- $288 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMGN
# of Institutions
2,969Shares Held
402MCall Options Held
6.59MPut Options Held
6.61M-
Vanguard Group Inc Valley Forge, PA52.1MShares$17.5 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$16.1 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.79 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.91 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.69 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $180B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...